Abstract
Cardiovascular diseases are the leading cause of morbidity and mortabilidade worldwide, and its prevalence more rapidly in low and middle income countries. Despite the reduction in the number of deaths after the discovery of statins, approximately 5% of patients develop adverse effects with the use of these drugs, which contraindicate its continued use. In addition, about 30% of individua…